AstraZeneca has announced the global withdrawal of its Oxford-AstraZeneca vaccine, also known as Vaxzevria and Covishield, after admitting it can cause severe side effects. During the Wuhan virus pandemic, then-Prime Minister Boris Johnson lauded AstraZeneca’s Covid vaccine as a “triumph for British science.”
AstraZeneca previously retracted its marketing authorization for the vaccine in the European Union (EU). Similar moves in the United Kingdom and other countries were expected. The corporation claims the decision was driven by “commercial reasons,” with new vaccines having superseded its original offering. However, the withdrawal follows an admission the vaccine can cause Thrombosis with Thrombocytopenia Syndrome (TTS), linked to 81 fatalities in Britain.
“It is admitted that the AZ vaccine can, in very rare cases, cause TTS,” AstraZeneca admitted in recent court filings, related to a lawsuit alleging their vaccine was “defective” and responsible for deaths and brain injuries.
The pharma giant continues to fight claims its product is responsible for causing Vaccine-Induced Thrombocytopenic Thrombosis (VITT) in a number of vaccine-injured people.
“The medical world has acknowledged for a long time that VITT was caused by the vaccine. It’s only AstraZeneca who have questioned whether Jamie’s condition was caused by the jab,” complained Kate Scott, whose husband Jamie Scott has permanent brain damage, following AstraZeneca’s admission of “very rare” cases of TTS.
Studies of coronavirus vaccines more broadly, including the mRNA-based formulations produced by Pfizer and Moderna, have linked them to blood, brain, and heart issues.